The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma –CLEAP 004 study by Chao-Xu Yang, Yang-Xun Pan, Feng Ye, Xiao-Dong Zhu, Jun Xue, Xi Li, Zhen-Gang Yuan, Lan Zhang, Li Xu, Yong-Jun Chen, Nan-Ya Wang, Hui-Chuan Sun, Xiu-Feng Liu, China Liver Cancer Study Group Young Investigators (CLEAP)

Get full text